Clinical associations of cerebral microbleeds on magnetic resonance neuroimaging

Journal of Stroke and Cerebrovascular Diseases

Volumn 23, Issue 10, 2014, Pages 2489-2497

  Schrag, Matthew ^a   Greer, David M ^a  

^a YALE NEW HAVEN HOSPITAL   (United States)

Author keywords

CADASIL; Cerebral amyloid angiopathy; COL4a1; Endocarditis; Gradient echo T2 ; Microbleeds

Indexed keywords

FIBRINOLYTIC AGENT; WARFARIN;

ALZHEIMER DISEASE; ANTICOAGULANT THERAPY; BRAIN EMBOLISM; BRAIN HEMORRHAGE; BRAIN INFARCTION; BRAIN INJURY; CADASIL; CEREBROVASCULAR ACCIDENT; COGNITIVE DEFECT; DEMENTIA; DIFFUSE AXONAL INJURY; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG SAFETY; ENDOCARDITIS; FIBRINOLYTIC THERAPY; GENETIC DISORDER; HUMAN; HYPERTENSION; MOYAMOYA DISEASE; NEUROIMAGING; NEUROPATHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; STROKE PATIENT; SYMPTOM; TRANSIENT ISCHEMIC ATTACK; VASCULAR AMYLOIDOSIS; WHITE MATTER; BRAIN; CEREBRAL HEMORRHAGE; MICROCIRCULATION; MORTALITY; PATHOLOGY; PROCEDURES; PROGNOSIS; TREATMENT OUTCOME; VASCULARIZATION;

BRAIN; CEREBRAL HEMORRHAGE; HUMANS; MAGNETIC RESONANCE IMAGING; MICROCIRCULATION; NEUROIMAGING; PROGNOSIS; TREATMENT OUTCOME;

EID: 84923300989     PISSN: 10523057     EISSN: 15328511     Source Type: Journal    
DOI: 10.1016/j.jstrokecerebrovasdis.2014.07.006     Document Type: Review

References (76)

1. Nandigam R, Vaswanathan A, Delgado P, et al. MR imaging detection of cerebral microbleeds: effect of susceptibility-weighted imaging, section thickness, and field strength. Am J Neuroradiol 2009;30:338-343.
2. Schrag M, McAuley G, Pomakian J, et al. Correlation of hypointensities in susceptibility-weighted images to tissue histology in dementia patients with cerebral amyloid angiopathy: a postmortem MRI study. Acta Neuropathol 2010;119:291-302.
3. Roob G, Schmidt R, Kapeller P, et al. MRI evidence of past cerebral microbleeds in a healthy elderly population. Neurology 1999;52:991.
4. Chowdhury M, Magai A, Bokura H, et al. Age-related changes in white matter lesions, hippocampal atrophy, and cerebral microbleeds in healthy subjects without major cerebrovascular risk factors. J Stroke Cerebrovasc Dis 2011;20:302-309.
5. Igase M, Tabara Y, Igase K, et al. Asymptomatic cerebral microbleeds seen in healthy subjects have a strong association with asymptomatic lacunar infarction. Circ J 2009; 73:530-533.
6. Jeerakathil T,Wolf P, Beiser A, et al. Cerebral microbleeds: prevalence and associations with cardiovascular risk factors in the Framingham Study. Stroke 2004;35:1831-1835.
7. Liu PF, Cui YZ, Na J, et al. Cerebral microbleeds - prevalence, distribution and risk factors in northeast population without preceding large-area stroke. Chin Med J 2010;123:286-290.
8. Ochi N, Tabara Y, Igase M, et al. Silent cerebral microbleeds associated with arterial stiffness in an apparently healthy subject. Hypertens Res 2009;32:255-260.
9. Qiu C, Cotch M, Sigurdsson S, et al. Cerebral microbleeds, retinopathy, and dementia: the AGES-Reykjavik Study. Neurology 2010;75:2221-2228.
10. Sveinbjornsdottir S, Sigurdsson S, Aspelund T, et al. Cerebral microbleeds in the population based AGESReykjavik study: prevalence and location. J Neurol Neurosurg Psychiatry 2008;79:1002-1006.
11. Takashima Y, Mori T, Hashimoto M, et al. Clinical correlating factors and cognitive function in communitydwelling healthy subjects with cerebral microbleeds. J Stroke Cerebrovasc Dis 2011;20:105-110.
12. Tsushima Y, Tanizaki Y, Aoki J, et al. MR detection of microhemorrhages in neurologically healthy adults. Neuroradiology 2002;44:31-36.
13. Poels M, Ikram M, van der Lugt A, et al. Incidence of cerebral microbleeds in the general population: the Rotterdam Scan Study. Stroke 2011;42:656-661.
14. Lee S, Bae H, Yoon B, et al. Low concentration of serum total cholesterol is associated with multifocal signal loss lesions on gradient-echo magnetic resonance imaging: analysis of risk factors for multifocal signal loss lesions. Stroke 2002;33:2845-2849.
15. Offenbacher H, Fazekas F, Schmidt R, et al. MR of cerebral abnormalities concomitant with primary intracerebral hematomas. AJNR Am J Neuroradiol 1996; 17:573-578.
16. Lee S, Park J, Kwon S, et al. Left ventricular hypertrophy is associated with cerebral microbleeds in hypertensive patients. Neurology 2004;63:16-21.
17. Patel B, Lawrence A, Chung A, et al. Cerebral microbleeds and cognition in patients with symptomatic small vessel disease. Stroke 2013;44:356-361.
18. Fazekas F, Kleinert R, Roob G, et al. Histopathologic analysis of foci of signal loss on gradient-echo T2∗-weighted MR images in patients with spontaneous intracerebral hemorrhage: evidence of microangiopathy-related microbleeds. Am J Neuroradiol 1999;20:637-642.
19. Altmann-Schneider I, Trompet S, de Craen A, et al. Cerebral microbleeds are predictive of mortality in the elderly. Stroke 2011;42:638-644.
20. Nighoghossian N, Hermier M, Adeleine P, et al. Old microbleeds are a potential risk factor for cerebral bleeding after ischemic stroke: a gradient-echo T2∗-weighted brain MRI study. Stroke 2002;33:735-742.
21. Fluri F, Jax F, Amort M, et al. Significance of microbleeds in patients with transient ischaemic attack. Eur J Neurol 2012;19:522-524.
22. Kamenar E, Burger P. Cerebral fat embolism: a neuropathological study of a microembolic state. Stroke 1980; 11:477-484.
23. Lee J. Gradient-echo MRI in defining the severity of cerebral fat embolism. J Clin Neurol 2008;4:164-166.
24. Miller N. Fat embolism of the brain. Cal West Med 1926; 25:215-217.
25. Sun S, Seol H, Seo W, et al. Cerebral fat embolism: susceptibility-weighted magnetic resonance imaging. Arch Neurol 2009;66:1170.
26. Goulenock T, Klein I, Mazighi M, et al. Infective endocarditis with symptomatic cerebral complications: contribution of cerebral magnetic resonance imaging. Cerebrovasc Dis 2013;35:327-336.
27. Klein U, Iung B, Labreuche J, et al. Cerebral microbleeds are frequent in infective endocarditis: a case-control study. Stroke 2009;40:3461-3465.
28. Okazaki S, Sakaguchi M, Hyun B, et al. Cerebral microbleeds predict impending intracranial hemorrhage in infective endocarditis. Cerebrovasc Dis 2012;13:703-710.
29. Sonneville R, Mirabel M, Hajage D, et al. Neurologic complications and outcomes of infectious endocarditis in critically ill patients: the ENDOcardite en REAnimation prospective multicenter study. Crit Care Med 2011; 39:1474-1481.
30. Werring DJ, Frazer DW, Coward LJ, et al. Cognitive dysfunction in patients with cerebral microbleeds on T2∗-weighted gradient-echo MRI. Brain 2004;127: 2265-2275.
31. Yakushiji Y, Noguchi T, Hara M, et al. Distributional impact of brain microbleeds on global cognitive function in adults without neurological disorder. Stroke 2012; 43:1800-1805.
32. Remes A, Finnila S, Mononen H, et al. Hereditary dementia with intracerebral hemorrhages and cerebral amyloid angiopathy. Neurology 2004;63:234-240.
33. Van den Boom R, Bornebroek M, Behloul F, et al. Microbleeds in hereditary cerebral hemorrhage with amyloidosis-Dutch type. Neurology 2005;64:1288-1289.
34. Apoil M, Cogez J, Dubuc L, et al. Focal cortical subarachnoid hemorrhage revealed by recurrent paresthesias: a clinico-radiological syndrome strongly associated with cerebral amyloid angiopathy. Cerebrovasc Dis 2013; 36:139-144.
35. Greenberg S, Vonsattel J, Stakes J, et al. The clinical spectrum of cerebral amyloid angiopathy: presentations without lobar hemorrhage. Neurology 1993; 43:2073-2079.
36. Nakata-Kudo Y, Mizuno T, Yamada K, et al. Microbleeds in Alzheimer disease are more related to cerebral amyloid angiopathy than cerebrovascular disease. Dement Geriatr Cogn Disord 2006;22:8-14.
37. Mesker D, Poels M, Ikram M, et al. Lobar distribution of cerebral microbleeds: the Rotterdam Scan Study. Arch Neurol 2011;68:656-659.
38. Maia L, Vasconcelos C, Seixas S, et al. Lobar brain hemorrhages and white matter changes: clinical, radiological and laboratorial profiles. Cerebrovasc Dis 2006; 22:155-161.
39. Greenberg S, Nandigam R, Delgado P, et al. Microbleeds versus macrobleeds: evidence for distinct entities. Stroke 2009;40:2382-2386.
40. Peca S, McCreary C, Domaldson E, et al. Neurovascular decoupling is associated with severity of cerebral amyloid angiopathy. Neurology 2013;81:1659-1665.
41. Brundel M, Heringa S, de Bresser J, et al. High prevalence of cerebral microbleeds at 7Tesla MRI in patients with early Alzheimer's disease. J Alzheimers Dis 2012; 31:259-263.
42. DeReuck J, Cordonnier C, Deramecourt V, et al. Microbleeds in postmortem brains of patients with Alzheimer disease: a T2∗-weighted gradient-echo 7.0 T magnetic resonance imaging study. Alzheimer Dis Assoc Disorder 2013;27:162-167.
43. Smith E, Greenberg S. Clinical diagnosis of cerebral amyloid angiopathy: validation of the Boston criteria. Curr Atheroscler Rep 2003;5:260-266.
44. Charidimou A, Peeters A, Jager R, et al. Cortical superficial siderosis and intracerebral hemorrhage risk in cerebral amyloid angiopathy. Neurology 2013;81:1666-1673.
45. Attems J, Lauda F, Jellinger KA. Unexpectedly low prevalence of intracerebral hemorrhage in sporadic cerebral amyloid angiopathy: an autopsy study. J Neurol 2008; 255:70-76.
46. Mendel T, Wierzba-Bobrowicz T, Stepien T, et al. Betaamyloid deposits in veins in patients with cerebral amyloid angiopathy and intracerebral haemorrhage. Folia Neuropathol 2013;51:120-126.
47. Van Rooden S, van der Grond J, van den Boom R, et al. Descriptive analysis of the Boston criteria applied to a Dutch-type cerebral amyloid angiopathy population. Stroke 2009;40:3022-3027.
48. Goos JD, Teunissen CE, Veerhuis R, et al. Microbleeds relate to altered amyloid-beta metabolism in Alzheimer's disease. Neurobiol Aging 2012;33:1011.
49. Renard D, Castelnovo G, Wacongne A, et al. Interest of CSF biomarker analysis in possible cerebral amyloid angiopathy cases defined by the modified Boston criteria. J Neurol 2012;259:2429-2433.
50. Van der Vlies AE, Goos JD, Barkhof F, et al. Microbleeds do not affect rate of cognitive decline in Alzheimer disease. Neurology 2012;79:763-769.
51. Chardimou A, Shakeshaft C, Werring D. Cerebral microbleeds on magnetic resonance imaging and anticoagulation-associated intracerebral hemorrhage risk. Front Neurol 2012;3:133.
52. Biffi A, Halpin A, Towfighi A, et al. Aspirin and recurrent intracerebral hemorrhage in cerebral amyloid angiopathy. Neurology 2010;75:693-698.
53. Greenberg S, Eng J, Ning M, et al. Hemorrhage burden predicts recurrent intracerebral hemorrhage after lobar hemorrhage. Stroke 2004;35:1415-1420.
54. Lovelock CE, Cordonnier C, Naka H, et al. Antithrombotic drug use, cerebral microbleeds, and intracerebral hemorrhage: a systematic review of published and unpublished studies. Stroke 2010;41:1222-1228.
55. Charidimou A, Kakar P, Fox Z, et al. Cerebral microbleeds and the risk of intracerebral hemorrhage after thrombolysis for acute ischaemic stroke: systematic review and meta-analysis. J Neurol Neurosurg Psychiatry 2013;84:277-280.
56. Tong K, Ashwal S, Holshouser B, et al. Hemorrhagic shearing lesions in children and adolescents with posttraumatic diffuse axonal injury: improved detection and initial results. Radiology 2003;227:332-339.
57. Scheid R, Preul C, Gruber O, et al. Diffuse axonal injury associated with chronic traumatic brain injury: evidence from T2∗-weighted gradient-echo imaging at 3 T. AJNR Am J Neuroradiol 2003;24:1049-1056.
58. Scheid R, Walther K, Guthke T, et al. Cognitive sequelae of diffuse axonal injury. Arch Neurol 2006;63:418-424.
59. Kikuta K, Takagi Y, Nozaki K, et al. Asymptomatic microbleeds in moyamoya disease: T2∗-weighted gradientecho magnetic resonance imaging study. J Neurosurg 2005;102:470-475.
60. Mori N, Miki Y, Kikuta K, et al. Microbleeds in moyamoya disease: susceptibility-weighted imaging versus T2∗-weighted imaging at 3 Tesla. Invest Radiol 2008; 43:574-579.
61. Kuroda S, Kashiwazaki D, Ishikawa T, et al. Incidence, locations, and longitudinal course of silent microbleeds in moyamoya disease: a prospective T2∗-weighted MRI study. Stroke 2013;44:516-518.
62. Ishikawa T, Kuroda S, Nakayama N, et al. Prevalence of asymptomatic microbleeds in patients with moyamoya disease. Neurol Med Chir (Tokyo) 2005;45:495-500.
63. Choi J, Song S, Lee J, et al. Diversity of stroke presentation in CADASIL: study from patients harboring the predominant NOTCH3 mutation R544C. J Stroke Cerebrovasc Dis 2013;22:126-131.
64. Cumurciuc R, Guichard JP, Reizine D, et al. Dilation of Virchow-Robin spaces in CADASIL. Eur J Neurol 2006; 13:187-190.
65. Dichgans M, Holtmannspotter M, Herzog J, et al. Cerebral microbleeds in CADASIL: a gradient-echo magnetic resonance imaging and autopsy study. Stroke 2002; 33:67-71.
66. Kim Y, Choi EJ, Choi CG, et al. Characteristics of CADASIL in Korea: a novel cysteine-sparing Notch3 mutation. Neurology 2006;66:1511-1516.
67. Lee JS, Choi JC, Kang S, et al. Effects of lacunar infarctions on cognitive impairment in patients with cerebral autosomal-dominant arteriopathywith subcortical infarcts and leukoencephalopathy. J Clin Neurol 2011;7:210-214.
68. Lesnik Oberstein S, van den Boom R, van Buchem A, et al. Cerebral microbleeds in CADASIL. Neurology 2001;57:1066-1070.
69. Liem M, Lesnik Oberstein S, Haan J, et al. MRI correlates of cognitive decline in CADASIL: a 7-year follow-up study. Neurology 2009;72:143-148.
70. Choi J, Kang S, Kang J, et al. Intracerebral hemorrhages in CADASIL. Neurology 2006;67:2042-2044.
71. Lafranconi S, Markus HS. COL4A1 mutations as a monogenic cause of cerebral small vessel disease: a systematic review. Stroke 2010;41:e513-e518.
72. Kivelev J, Niemelarist M, Kivisaari R, et al. Long-term outcome of patients with multiple cerebral cavernous malformations. Neurosurgery 2009;65:450-455.
73. Al-Holou WM, O'Lynnger TM, Pandey AS, et al. Natural history and imaging prevalence of cavernous malformations in children and young adults. J Neurosurg Pediatr 2012;9:198-205.
74. De Champfleur NM, Langlois C, Ankenbrandt W, et al. Magnetic resonance imaging evaluation of cerebral cavernous malformations with susceptibility-weighted imaging. Neurosurgery 2011;68:641-647.
75. Lehnhardt FG, von Smekal U, Ruchriem B, et al. Value of gradient-echo magnetic resonance imaging in the diagnosis of familial cerebral cavernous malformation. Arch Neurol 2005;62:653-658.
76. Feng W, Sidorov E, Smith K, et al. Recurrent lobar intracerebral hemorrhage in Tangier disease. J Stroke Cerebrovasc Dis 2012;21:909.